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Abstract 
Acute kidney injury (AKI) is a clinical syndrome with diverse pathophysiology. It is associated with 
increased mortality rate and hospitalization time. Different biomarkers are used for early diagnosis of AKI 
including Kidney injury molecule-1 (KIM-1). The aim of this study is to determine the association between 
KIM-1 gene polymorphism and AKI in Lebanese hospitalized patients. Blood samples were collected from 
fifty AKI patients and forty controls from the Beqaa and North Lebanon to isolate the genomic DNA. 
Polymerase chain reaction (PCR) was used to amplify exon 4. The amplified PCR products were 
sequenced. Eleven variations were identified in exon 4 that showed significant association with 
susceptibility to AKI (P ≤ 0.05). Data analysis suggested that carriers of the risk allele of 5 SNPs had an 
increased predisposition to the disease. Only 3 SNPs out 11 showed association with serum parameters; 
rs184276926 and rs10068551 were significantly associated with increased creatinine and urea levels 
while rs764873440 was associated with urea level only. On the other hand, no association was observed 
between AKI susceptibility and several clinical parameters. Haplotype analysis showed significant 
association of 3 haplotype blocks with AKI incidence but not with creatinine/urea levels. In conclusion, 
our findings showed an association between KIM-1 exon 4 polymorphisms and susceptibility to acute 
kidney injury. 
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ABSTRACT: Acute kidney injury (AKI) is a clinical syndrome with diverse pathophysiology. It is 
associated with increased mortality rate and hospitalization time. Different biomarkers are used for 
early diagnosis of AKI including Kidney injury molecule-1 (KIM-1). The aim of this study is to 
determine the association between KIM-1 gene polymorphism and AKI in Lebanese hospitalized 
patients. Blood samples were collected from fifty AKI patients and forty controls from the Beqaa 
and North Lebanon to isolate the genomic DNA. Polymerase chain reaction (PCR) was used to 
amplify exon 4. The amplified PCR products were sequenced. Eleven variations were identified in 
exon 4 that showed significant association with susceptibility to AKI (P ≤ 0.05). Data analysis 
suggested that carriers of the risk allele of 5 SNPs had an increased predisposition to the disease. 
Only 3 SNPs out 11 showed association with serum parameters; rs184276926 and rs10068551 were 
significantly associated with increased creatinine and urea levels while rs764873440 was 
associated with urea level only. On the other hand, no association was observed between AKI 
susceptibility and several clinical parameters. Haplotype analysis showed significant association 
of 3 haplotype blocks with AKI incidence but not with creatinine/urea levels. In conclusion, our 
findings showed an association between KIM-1 exon 4 polymorphisms and susceptibility to acute 
kidney injury. 
 
KEYWORDS: Acute kidney injury; Haplotype, KIM-1; Polymorphism. 
 
 
1. INTRODUCTION 
Acute kidney injury (AKI) is a serious health problem. AKI patients have markedly increased mortality rate and 
are characterized by an acute decline in renal function (Uchino et al., 2005). Recently, many studies tackled the 
role of genetic variations in AKI occurrence and the severity of this disease (He et al., 2018; Leung et al., 2009; 
Susantitaphong et al., 2013). Creatinine and other urine output tests were considered the gold standard of AKI 
biomarkers. However, more specific and sensitive biomarkers are used nowadays, specifically the kidney injury 
molecule-1 (KIM-1), an important biomarker for AKI and kidney failure (Martensson et al., 2012). KIM-1, also 
known as T cell immunoglobulin and mucin-1 (TIM-1) or hepatitis A virus cellular receptor 1 (HAVCR1), is a type 
I transmembrane glycoprotein expressed in the proximal tubular epithelial cells (Vaidya et al., 2008). The precise 
role of KIM-1 in renal injury and repair and whether its expression enhances renal protection from nephrotoxic 
insult is not well established (Rees & Kain, 2008). It was demonstrated as an early sensitive and specific diagnostic 
marker for kidney injury in humans and rats exposed to toxic substances (Vaidya et al., 2006).  
 
Genetic polymorphisms of KIM-1 have major effects on its function in the immune system and thus 
susceptibility to immune diseases (Meyers et al., 2005). No previous studies addressed the association between 
KIM-1 gene polymorphism and AKI. The aim of this study is to examine the relationship between KIM-1 gene 
polymorphism and acute kidney injury in Lebanese hospitalized patients. 
 
2. MATERIALS AND METHODS 
2.1 Study Subjects and Data Collection 
After approval of the “Institutional Review Board” at Beirut Arab University code number 2018H-0035-S-P-
0277, fifty AKI patients (28 male and 22 females) and 40 control (21 male and 19 females) were recruited for this 
study. All participants signed an informed consent form. Patients were recruited from several hospitals in North 
Lebanon and from Beqaa between November 2017 and May 2018. Control patients were recruited from the same 
regions. Patients under the age of 18, pregnant women, and those having creatinine level <1.9 mg/dL were 
excluded. Detailed clinical history records were collected in a well-designed questionnaire including baseline 
demographic characteristics with comorbid and coexisting conditions. Kidney-related parameters including serum 
creatinine and blood urea nitrogen (BUN) were retrieved from hospitals’ records. 
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2.2 Isolation of DNA and PCR Amplification 
Blood specimens were collected in tubes containing ethylenediaminetetra-acetic acid (EDTA) from patients and 
controls. DNA samples were extracted from whole blood by using the GenElute extracted kit (Sigma Aldrich) 
according to manufacturer’s recommendation.  
 
2.3 PCR Amplification and Sequencing 
The highly polymorphic exon 4 of KIM-1 gene (NC_000005.10) was amplified by polymerase chain reaction 
(PCR) using the sense 5’ GTTTGACTTATGCTCACTCTC 3’ and antisense 5’ CCTCACTCTAGACTGTCCTTC 
3’ primers (Page et al., 2006). PCR was done in a total volume of 25 µl containing 1.5 µl template DNA (10 ng), 
0.5 µl of forward and reverse primers (10 µM), 12.5 µl of 2x PCR Master Mixture (Sigma-Aldrich) and 10 µl of 
nuclease free water. PCR was performed as follows: 1 cylce at 95˚C for 3 min, followed by 35 cycles consisting 
of 30 s at 95˚C, 20 s at 50˚C and 30 s at 72˚C and 1 cycle at 72˚C for 4 min. The size of the obtained PCR products 
(391bp) was confirmed on 2% agarose electrophoresis and visualized using the ChemiDoc-It imaging system 
(BIO-RAD, California, USA ChemiDoc-It®2 515 Imager P/N 95-0441-04). The amplified fragments were 
purified using GenElute PCR Clean-Up Kit (Sigma) and sent for sequencing at Macrogen, Korea. 
 
2.4 SNP Selection 
Single nucleotide polymorphisms (SNPs) were chosen for genotyping based on the NCBI SNP database 
(http://www.ncbi.nlm.nih.gov). Eleven KIM-1 gene SNPs were selected within exon 4 for genotyping (rs2862716, 
rs10068551, rs199928074, rs764873440, rs1301776051, rs1195142602, rs184276926, rs776819911, 
rs1239820074, rs757452379, and rs200904360). 
 
2.5 Statistical Analysis 
All statistical analyses were performed using SPSS version 23. Chi-square for comparison between means and 
One-way ANOVA for association between SNPs and haplotypes with serum parameters. Odd’s ratio (OR) and 
95% interval confidence (CI) were applied to assess risk factors. P-value of ≤ 0.05 was considered significant. 
 
3. RESULTS 
Table 1 shows the characteristics of AKI patients and the healthy controls. The mean age were 56.9 and 53.0 
years with an average creatinine level of 3.87 and 1.01 mg/dL and blood urea nitrogen of 140.5 and 23.5 mg/dL, 
respectively.  
 
Table 1: Characteristics of patients and controls 
 AKI patients Controls P-value 
 (n= 50) (n= 40)  
Age 56.9±20.4 53.0±20.3 0.381 
Gender (male:female) 28:22 21:19 0.744 
BMI 26.07±4.89 27±5.6 0.386 
Creatinine (mg/dL) 3.87±2.15 1.01±0.16 0.000 
Blood urea nitrogen (mg/dL) 140.5±71.17 23.5±2.4 0.000 
 
 
3.1 Genotype and Allele Frequencies of Selected SNPs 
Table 2 shows the genotype and allele frequencies of the eleven selected SNPs in KIM-1 exon 4 of for all 
participants.  All studied SNPs showed significant differences (P ≤ 0.05) in the genotypic frequencies between 
AKI patients and controls. However, only 5 SNPs showed significant differences in the allelic frequencies.  
 
Table 2: Distribution of the genotype and allele frequencies of KIM-1 gene in AKI patients and controls 
 AKI 
N (%) 
Control 
N (%) 
 P-values OR (95% CI) 
rs2862716      
Genotype frequency      
TT 11 (22%) 22 (55%)   Reference Genotype 
TC 29 (58%) 2 (5%) (TC+CC ) vs. 
TT 
0.001* 1.733 
(1.194-2.517) 
CC 10 (20%) 16 (40%)    
Allele frequency      
Allele T 21 (42%) 24 (60%)   Reference 
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Allele 
Allele C 29 (58%) 16 (40%) C vs. T 0.090 1.450 
(0.927-2.267) 
rs10068551      
Genotype frequency      
GG 0 (0%) 6 (15%)   Reference Genotype 
GA 17 (34%) 0 (0%) (GA+AA) vs. 
GG 
0.005* 1.111 
(1.002-1.232) 
AA 33 (66%) 34 (85%)    
Allele frequency      
Allele G 4 (8%) 6 (15%)   Reference 
Allele 
Allele A 46 (92%) 34 (85%) A vs. C 0.294 0.924 
(1.033-1.340) 
rs199928074      
Genotype frequency      
GG 2 (4%) 20 (50%)   Reference Genotype 
GA 38 (76%) 2 (5%) (GA+AA) vs. 
GG 
0.000* 1.920 
(1.401-2.631) 
AA 10 (20%) 18 (45%)    
Allele frequency      
Allele G 31 (62%) 22 (55%)   Reference 
Allele 
Allele A 19 (38%) 18 (45%) A vs. G 0.502 0.844 
(0.516-1.382) 
rs764873440      
Genotype frequency      
CC 36 (72%) 40 (100%)   Reference Genotype 
CT 13 (26%) 0 (0%) (CT+TT) 
vs. CC 
0.000* 1.389 
(1.168-1.651) 
TT 1 (2%) 0 (0%)    
Allele frequency      
Allele C 38 (76%) 40 (100%)   Reference 
Allele 
Allele T 12 (24%) 0 (0%) T vs. C 0.001* 0.760 
(0.650-.888) 
rs1301776051      
Genotype frequency      
AA 19 (38%) 0 (0%)   Reference Genotype 
AG 28 (56%) 2 (5%) (AG+GG ) vs. 
AA 
0.000* 0.620 
(0.499-0.770) 
GG 3 (6%) 38 (95%)    
Allele frequency      
Allele A 22 (44%) 38 (95%)   Reference 
Allele 
Allele G 28 (56%) 2 (5%) G vs. A 0.000* 0.463 
(0.336-0.638) 
rs1195142602      
Genotype frequency      
CC 5 (10%) 20 (50%)   Reference Genotype 
CT 36 (72%) 2 (5%) (CT+TT) vs. 
CC 
0.000* 1.800 
(1.303-2.487) 
TT 9 (18%) 18 (45%)    
Allele frequency      
Allele C 23 (46%) 20 (50%)   Reference 
Allele 
Allele T 27 (54%) 20 (50%) T vs. C 0.706 1.080 
(0.723-1.614) 
rs184276926      
Genotype frequency      
AA  20 (40%) 40 (100%)   Reference Genotype 
AG 18 (36%) 0 (0%) (AG+GG) vs. 
AA 
0.000* 0.400 
(0.285-0.562) 
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GG 12 (24%) 0 (0%)    
Allele frequency      
Allele A 32 (64%) 40 (100%)   Reference 
Allele 
Allele G 18 (36%) 0 (0%) G vs. A 0.000* 0.640 
(0.520-0.788) 
rs776819911      
Genotype frequency      
GG 2 (4%) 12 (30%)   Reference Genotype 
GA 38 (76%) 2 (5%) (GA+AA) vs. 
GG 
0.001* 1.371 
(1.111-1.693) 
AA 10 (20%) 26 (65%)    
Allele frequency      
Allele G 17 (34%) 14 (35%)   Reference 
Allele 
Allele A 33 (66%) 26 (65%) A vs. G 0.921 1.015 
(0.751-1.374) 
rs1239820074      
Genotype frequency      
CC 3 (6%) 24 (60%)   Reference Genotype 
CT 30 (60%) 0 (0%) (CT+TT) vs. 
CC 
0.000* 2.350 
(1.598-3.457) 
TT 17 (34%) 16 (40%)    
Allele frequency      
Allele C 4 (8%) 24 (60%)   Reference 
Allele 
Allele T 46 (92%) 16 (40%) T vs. C 0.000* 2.300 
(1.56-3.391) 
rs757452379      
Genotype frequency      
AA 22 (44%) 38 (95%)   Reference Genotype 
AC 22 (44%) 2 (5%) (AC+CC) vs. 
AA 
0.000* 0.442 
(0.317-0.617) 
CC 6 (12%) 0 (0%)    
Allele frequency      
Allele A 22 (44%) 38 (95%)   Reference 
Allele 
Allele C 28 (56%) 2 (5%) C vs. A 0.000* 0.463 
(0.336-0.638) 
rs200904360      
Genotype frequency      
TT 3 (6%) 22 (55%)   Reference Genotype 
TC 39 (78%) 2 (5%) (TC+CC) vs. 
TT 
0.000* 1.067 
(1.472-2.963) 
CC 8 (16%) 16 (40%)    
Allele frequency      
Allele T 32 (64%) 24 (60%)   Reference 
Allele 
Allele C 18 (36%) 16 (40%) C vs. T 0.697 0.900 
(0.530-1.529) 
*Significant (P ≤ 0.05) values are in bold. 
3.2 Haplotypes Frequencies among AKI Patients and Controls 
In order to investigate the potential association between the studied SNPs and AKI, haplotype analyses were 
performed. Subsequent haplotype analysis revealed that 2 SNPs (rs10068551 and rs1239820074) formed one 
haplotype block. An overall of 4 haplotypes were generated, among which three haplotypes (AT, AC, and GC) 
showed significant differences between patients and controls. AT seems to provide a higher risk for the acute 
kidney injury occurrence, while AC and GC seem to confer protection against the disease as shown in Table 3. 
 
 
Table 3: Haplotype frequencies in AKI patients and control subjects 
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Haplotype AKI 
N (%) 
Control 
N (%) 
P-value OR (95% CI) 
AT 42 (84%) 17 (42.5%) 0.000* 0.278 
(0.140-0.554) 
GT 3 (6%) 0 (0%) 0.074 0.940 
(0.876-1.008) 
AC 4 (8%) 17 (42.5%) 0.000* 1.600 
(1.211-2.114) 
GC 1 (2%) 6 (15%) 0.036* 1.111 
(1.002-1.232) 
*Significant (P ≤ 0.05) values are in bold. 
3.3 Association between KIM-1 Polymorphism and Serum Creatinine and Urea Levels in AKI Patients 
Association analysis between KIM-1 genetic polymorphisms and serum creatinine and urea levels is shown in 
Table 4. Both rs10068551 and rs184276926 were significantly associated with serum creatinine and urea levels in 
AKI patients. However, rs764873440 was significantly associated only with urea levels. 
 
Table 4: Differences in the value of serum creatinine and urea among AKI patients stratified by different KIM-1 genotypes. 
SNP Genotype Samples 
number (%) 
Creatinine 
(mg/dL) 
P-values Urea (mg/dL) P-values 
rs2862716 TT 11 (22%) 2.85±0.63 0.103 118.36±46.48 0.373 
TC 29 (58%) 4.24±2.31 140.2±70.63 
CC 10 (20%) 3.92±2.51 165.7±91.37 
rs10068551 GG 0 (0%)  0.042*  0.003* 
AG 17 (34%) 2.88±0.15 97.53±9.9 
AA 33 (66%) 4.38±0.43 162.64±12.33 
rs199928074 GG 2 (4%) 3.15±0.68 0.710 115.5±32.47 0.569 
AG 38 (76%) 3.9±0.34 135.18±10.46 
AA 10 (20%) 3.89±0.77 165.7±28.05 
rs764873440 CC 36 (72%) 3.19±0.21 0.436 115.7±9.17 0.033* 
CT 13 (26%) 5.28±0.74 191.9±15.2 
TT 1 (2%) 10 365 
rs1301776051 AA 19 (38%) 3.14±0.22 0.242 119.26±13.36 0.131 
AG 28 (56%) 4.19±0.44 145.1±12.89 
GG 3 (6%) 5.53±1.93 232±54.96 
 
rs1195142602 
 
CC 5 (10%) 3.06±0.32 0.571 133.2±24.21 0.897 
CT 36 (72%) 3.92±0.35 132.33±10.66 
TT 9 (18%) 4.1±0.84 177.22±28.75 
rs184276926 AA 20 (40%) 3.02±0.3 0.01* 98.65±10.14 0.000* 
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AG 18 (36%) 4.8±0.56 175.28±14.22 
GG 12 (24%) 3.88±0.65 158.1±25.55 
rs776819911 GG 2 (4%) 3.15±0.68 0.710 115.5±32.51 0.569 
GA 38 (76%) 3.9±0.35 135.03±11.05 
AA 10 (20%) 3.89±0.76 166.3±27.45 
rs1239820074 CC 3 (6%) 2.9±0.49 0.379 108.67±22.39 0.438 
CT 30 (60%) 4.2±0.4 151.33±11.53 
TT 17 (34%) 3.46±0.45 127±19.35 
rs757452379 AA 22 (44%) 4.07±0.54 0.792 155.09±16.28 0.218 
AT 22 (44%) 3.59±0.4 122.18±12.9 
TT 6 (12%) 4.14±0.7 154.17±29.82 
rs200904360 TT 3 (6%) 4.22±0.5 0.220 166.95±16.57 0.391 
TC 39 (78%) 3.59±0.36 119.71±10.54 
CC 8 (16%) 5.032±1.82 197.37±38.53 
*Significant (P ≤ 0.05) values are in bold. aMeans ± SD 
 
3.4 Association between Haplotypes and Serum Parameters (Creatinine and Urea Levels) in AKI Patients 
After determining haplotype frequencies among AKI patients, their association with serum creatinine and urea 
was investigated. No association was determined between any of the haplotypes and serum parameters as shown 
in Table 5. 
Table 5: Association between haplotypes in KIM-1 and serum parameters. 
Haplotype Samples number 
(%) 
Creatinine 
(mg/dL) 
P-values Urea 
(mg/dL) 
P-values 
AT 40 (80%) 3.16±2.36 0.513 110.54.52±83.95 0.413 
GT 4 (8%) 3.13±0.56 0.150 74.66±13.51 0.180 
AC 2 (4%) 1.38±0.85 0.750 41.04±29.21 0.778 
GC 2 (4%) 1.3±0.97 0.954 51.14±25.81 1 
 
3.5 Association between AKI Susceptibility and Different Parameters 
Statistical analyses were performed to investigate the association between AKI susceptibility and different 
parameters including gender, AKI symptoms, diseases, smoking, and others as shown in Table 6. No significant 
correlation between these parameters and the disease (Data not shown). Differences in these parameters between 
AKI patients and controls are shown in Table 6. 
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 Table 6: Baseline parameters and clinical data of AKI patients and controls 
Parameters AKI Patients 
(n=50) 
Control 
(n=40) 
 Yes (%) No (%) No (%) Yes (%) 
Any symptom of AKI 23 (46%) 27 (54%) 0 (0%) 40 (100%) 
Any family member with kidney 
diseases 
15 (30%) 35 (70%) 6 (15%) 34 (85%) 
Heart disease 13 (26%) 37 (74%) 16 (40%) 24 (60%) 
Diabetes 12 (24%) 38 (76%) 10 (25%) 30 (75%) 
Blood pressure problems 20 (40%) 30 (60%) 20 (50%) 20 (50%) 
Anemia 17 (34%) 33 (66%) 14 (35%) 26 (65%) 
Severe dehydration 9 (18%) 41 (82%) 8 (20%) 32 (80%) 
Weak immunity 10 (20%) 40 (80%) 6 (15%) 34 (85%) 
Liver problems 2 (4%) 48 (96%) 6 (15%) 34 (85%) 
Pulmonary disease 9 (18%) 41 (82%) 12 (30%) 28 (70%) 
Did any surgery or organ 
transplantation 
30 (60%) 20 (40%) 22 (55%) 18 (45%) 
Received a blood transfusion 23 (46%) 27 (54%) 14 (35%) 26 (65%) 
Smoking 19 (38%) 31 (62%) 20 (50%) 20 (50%) 
Drink caffeinated beverages 40 (80%) 10 (20%) 32 (80%) 8 (20%) 
Consume alcohol 0 (0%) 50 (100%) 2 (5%) 38 (95%) 
 
4. DISCUSSION 
We report in this study evidence relating the genetic variation in KIM-1 with susceptibility to AKI. KIM-1 plays 
a critical role in regulating immune response and is linked to susceptibility to autoimmune diseases (Garcia-Lozano 
et al., 2010). KIM-1 exon 4 is highly polymorphic among its 9 exonic regions. Association of exon 4 polymorphism 
with human atopic diseases was first shown in 2003 (McIntire et al., 2003). It was associated with allergic diseases 
(asthma and atopic dermatitis) and rheumatoid arthritis (Chae et al., 2003). Other studies identified associations 
between variations in different genes and AKI.  Isbir et al. found an association between angiotensin-converting 
enzyme (ACE) and apolipoprotein E (APO E) genes polymorphisms and AKI occurrence post cardiac surgery. 
However, no association was demonstrated between the disease and angiotensin II type 1 receptor (AGTR1) 
polymorphism (Isbir et al., 2007). Moreover, no association was found between AKI incidence and catalase, the 
oxidative stress gene (Perianayagam et al., 2007) nor with genes involved in inflammatory/anti-inflammatory 
pathways (Stafford-Smith et al., 2005; Treszl et al., 2002). On the other hand, association between SNPs in the 
promoter region of TNF and IL10 and the decreased death risk in AKI patients was demonstrated (Jaber et al., 
2004). Likewise, association between NFB Inhibitor alpha gene and AKI incidence was reported (Bhatraju et al., 
2015). 
 
The present study supports further the role for KIM-1 genetic variation in modulating AKI risk in Lebanese 
population. Specific KIM-1 SNPs associated with susceptibility to acute kidney injury are identified. Eleven SNPs 
within KIM-1 exon 4 were investigated where significant association with susceptibility to acute kidney injury was 
observed. Significant differences in the genetic frequencies between patients and controls were observed. On the 
7
Borjac: KIM-1 GENE POLYMORPHISM AND ACUTE KIDNEY INJURY IN THE LEBANESE P
Published by Digital Commons @ BAU, 2019
other hand, allelic frequencies were significantly different in only five out of the eleven SNPs (rs764873440, 
rs1301776051, rs184276926, rs1239820074, rs757452379). 
 
From these SNPs, only rs184276926 and rs10068551 were found to be significantly associated with increased 
in both creatinine and urea levels in serum. Patients with AG and AA genotypes respectively showed higher serum 
creatinine and urea levels than those with other genotype. However, rs764873440 showed a significant association 
with urea level only.  Patients with TT genotype showed higher urea level than those with other genotypes. 
Knowing that creatinine is secreted by proximal tubule (Musso et al., 2009), and that urea is partially reabsorbed 
by this tubule (Gowda et al., 2010), our results suggest that the genetic polymorphism of KIM-1 may lead to 
alteration in its function which in turn may affect creatinine tubular secretion and urea tubular reabsorption and 
thereby altering their levels in serum.  
 
We also identified 4 haplotypes consisting of 2 SNPs in KIM-1. Among these haplotypes, 3 showed a significant 
difference between AKI patients and controls. However, no significant association was detected between these 
haplotypes and serum parameters. 
 
5. CONCLUSIONS 
This is the first study to describe an association between polymorphisms in KIM-1 and AKI. Several SNPs and 
haplotypes within exon 4 of KIM-1 are shown to be associated with susceptibility to AKI in Lebanese population. 
The present study suggests that KIM-1 may be a good candidate for acute kidney injury prognosis. Future studies 
with larger number of participants are needed to clarify the role of genetic variation in determining the risk of AKI 
among the Lebanese and other populations. 
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